Reply letter to "Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design".

导出 OA

翻译打印收藏纠错

作者： Sanjay,Hadigal ^[1] ; Laura,Colombo ^[2] ; Scott,Haughie ^[3]

作者单位： Department of Medical Affairs, Viatris, India. ^[1] Department of Medical Affairs, Viatris, Italy. ^[2] Department of Biometrics, Viatris, UK. ^[3]

关键词 Number needed to vaccinate flu influenza vaccine recombinant quadrivalent vaccine standard-dose quadrivalent vaccine vaccine coverage vaccine shortage

主题词人类(Humans);流感疫苗(Influenza Vaccines);流感, 人(Influenza, Human);回顾性研究(Retrospective Studies);门诊病人(Outpatients);接种(Vaccination);季节(Seasons)

DOI 10.1080/21645515.2023.2227034

PMID 37344371

发布时间 2023-07-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Human vaccines & immunotherapeutics

2023年19卷2期

2227034页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Reply letter to "Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design".

Human vaccines & immunotherapeutics

相似文献

Human vaccines & immunotherapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Reply letter to "Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design".

Human vaccines & immunotherapeutics

相似文献

Human vaccines & immunotherapeutics

相关期刊

检索历史清除